Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD-Deleted Cancers.
TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD-Deleted Cancers.
Journal: Cancer discovery
Published: January 12, 2026
Decoding MnO2 redox chemistry from mechanistic ambiguity to design principles for aqueous Zn-ion batteries.
Journal: Nature communications
Published: December 01, 2025
Evaluating Hospital Course Summarization by an Electronic Health Record-Based Large Language Model.
Journal: JAMA network open
Published: August 13, 2025
Preclinical and clinical evaluation of a novel TRPA1 antagonist LY3526318.
Journal: Pain
Published: July 22, 2024
Opinion Mining by Convolutional Neural Networks for Maximizing Discoverability of Nanomaterials.
Journal: Journal of chemical information and modeling
Published: November 20, 2023
Orally Bioavailable Enzymatic Inhibitor of CD38, MK-0159, Protects against Ischemia/Reperfusion Injury in the Murine Heart.
Journal: Journal of medicinal chemistry
Published: June 28, 2022
Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial.
Journal: JAMA internal medicine
Published: December 13, 2021
Temporal Changes in Size and Dermoscopic Patterns of New and Existing Nevi in Adolescents.
Journal: The Journal of investigative dermatology
Published: October 20, 2018
Reference values for skin microanatomy: A systematic review and meta-analysis of ex vivo studies.
Journal: Journal of the American Academy of Dermatology
Published: February 02, 2017
Contemporary approaches to basal cell carcinoma diagnosis and treatment.
Journal: Future oncology (London, England)
Published: November 11, 2015
Burden of basal cell carcinoma in USA.
Journal: Future oncology (London, England)
Published: October 16, 2015
Last Updated: 09/26/2026